Literature DB >> 21158470

Full protein flexibility is essential for proper hot-spot mapping.

Katrina W Lexa1, Heather A Carlson.   

Abstract

A traditional technique for structure-based drug design (SBDD) is mapping of protein surfaces with probe molecules to identify "hot spots" where key functional groups can best complement the receptor. Common methods, such as minimization of probes or calculation of grids, use a fixed protein structure in the gas phase, ignoring both protein flexibility and proper competition between the probes and water. As a result, the potential surface is quite rugged, and many spurious local minima are identified. In this work, we compared rigid and fully flexible proteins in mixed-solvent molecular dynamics, which allows for flexibility and full solvent effects. We were surprised to find that the large number of local minima are still found when a protein's conformational sampling is restricted; the dynamic averaging of probes and competition with water do not smooth the potential surface as one might expect. Only when a protein is allowed to be fully flexible in the simulation are the proper minima located and the spurious ones eliminated. Our results indicate that inclusion of full protein flexibility is critical to accurate hot-spot mapping for SBDD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21158470      PMCID: PMC3081398          DOI: 10.1021/ja1079332

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  16 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  MCSS functionality maps for a flexible protein.

Authors:  C M Stultz; M Karplus
Journal:  Proteins       Date:  1999-12-01

3.  Computational mapping identifies the binding sites of organic solvents on proteins.

Authors:  Sheldon Dennis; Tamas Kortvelyesi; Sandor Vajda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

4.  Incorporating protein flexibility in structure-based drug discovery: using HIV-1 protease as a test case.

Authors:  Kristin L Meagher; Heather A Carlson
Journal:  J Am Chem Soc       Date:  2004-10-20       Impact factor: 15.419

5.  X-ray studies on cross-linked lysozyme crystals in acetonitrile-water mixture.

Authors:  Z Wang; G Zhu; Q Huang; M Qian; M Shao; Y Jia; Y Tang
Journal:  Biochim Biophys Acta       Date:  1998-05-19

Review 6.  Locating and characterizing binding sites on proteins.

Authors:  C Mattos; D Ringe
Journal:  Nat Biotechnol       Date:  1996-05       Impact factor: 54.908

7.  A computational procedure for determining energetically favorable binding sites on biologically important macromolecules.

Authors:  P J Goodford
Journal:  J Med Chem       Date:  1985-07       Impact factor: 7.446

8.  Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques.

Authors:  Ryan Brenke; Dima Kozakov; Gwo-Yu Chuang; Dmitri Beglov; David Hall; Melissa R Landon; Carla Mattos; Sandor Vajda
Journal:  Bioinformatics       Date:  2009-01-28       Impact factor: 6.937

9.  A poke in the eye: inhibiting HIV-1 protease through its flap-recognition pocket.

Authors:  Kelly L Damm; Peter M U Ung; Jerome J Quintero; Jason E Gestwicki; Heather A Carlson
Journal:  Biopolymers       Date:  2008-08       Impact factor: 2.505

10.  Computational fragment-based binding site identification by ligand competitive saturation.

Authors:  Olgun Guvench; Alexander D MacKerell
Journal:  PLoS Comput Biol       Date:  2009-07-10       Impact factor: 4.475

View more
  46 in total

Review 1.  Fine-tuning multiprotein complexes using small molecules.

Authors:  Andrea D Thompson; Amanda Dugan; Jason E Gestwicki; Anna K Mapp
Journal:  ACS Chem Biol       Date:  2012-07-23       Impact factor: 5.100

2.  Balancing target flexibility and target denaturation in computational fragment-based inhibitor discovery.

Authors:  Theresa J Foster; Alexander D MacKerell; Olgun Guvench
Journal:  J Comput Chem       Date:  2012-05-28       Impact factor: 3.376

Review 3.  An overview of recent molecular dynamics applications as medicinal chemistry tools for the undruggable site challenge.

Authors:  Ugo Perricone; Maria Rita Gulotta; Jessica Lombino; Barbara Parrino; Stella Cascioferro; Patrizia Diana; Girolamo Cirrincione; Alessandro Padova
Journal:  Medchemcomm       Date:  2018-04-19       Impact factor: 3.597

4.  Biomolecular Solvation Structure Revealed by Molecular Dynamics Simulations.

Authors:  Michael E Wall; Gaetano Calabró; Christopher I Bayly; David L Mobley; Gregory L Warren
Journal:  J Am Chem Soc       Date:  2019-03-11       Impact factor: 15.419

Review 5.  Computational functional group mapping for drug discovery.

Authors:  Olgun Guvench
Journal:  Drug Discov Today       Date:  2016-07-05       Impact factor: 7.851

Review 6.  Driving Structure-Based Drug Discovery through Cosolvent Molecular Dynamics.

Authors:  Phani Ghanakota; Heather A Carlson
Journal:  J Med Chem       Date:  2016-08-17       Impact factor: 7.446

7.  Identifying binding hot spots on protein surfaces by mixed-solvent molecular dynamics: HIV-1 protease as a test case.

Authors:  Peter M U Ung; Phani Ghanakota; Sarah E Graham; Katrina W Lexa; Heather A Carlson
Journal:  Biopolymers       Date:  2016-01       Impact factor: 2.505

8.  Improving protocols for protein mapping through proper comparison to crystallography data.

Authors:  Katrina W Lexa; Heather A Carlson
Journal:  J Chem Inf Model       Date:  2013-02-13       Impact factor: 4.956

9.  Discovery of small molecule inhibitors of adenovirus by disrupting E3-19K/HLA-A2 interactions.

Authors:  Jinhong Ren; Nikita R Dsouza; Hui Deng; Hyun Lee; Marlene Bouvier; Michael E Johnson
Journal:  Bioorg Med Chem Lett       Date:  2018-07-29       Impact factor: 2.823

Review 10.  Expanding the number of 'druggable' targets: non-enzymes and protein-protein interactions.

Authors:  Leah N Makley; Jason E Gestwicki
Journal:  Chem Biol Drug Des       Date:  2013-01       Impact factor: 2.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.